developer, manufacturer and distributor of pharmaceuticals
Issues related to health care, the Food and Drug Administration (FDA), 340B Program, drug pricing, importation of biopharmaceuticals, international pharmaceutical supply chain, TRICARE Pharmacy Program, education around COVID-19 therapies, and antimicrobial resistance legislation.
Implementation of Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (P.L.116-22). 
S.909, The Prescription Drug Price Relief Act; S.908, The Medicare Drug Price Negotiation Act; S.920, The Affordable and Safe Prescription Drug Importation Act. Biopharmaceutical innovation and patent policy issues.
Trademark legislative proposals.
Bayh-Dole march-in rights policy issues. Issues related to pharmaceutical IP and supply chain; S.1260, United States Innovation and Competition Act of 2021. Implementation of Tax Cuts and Jobs Act (P.L.115-97). General issues related to Medicare and Medicaid, including: Part D Medicare Program; Medicare Part B reimbursement; Proposed Part B IPI Demonstration Project; Drug Pricing; Medicaid rebates and AMP Cap;      
H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation; H.R.1868, To prevent across-the-board direct spending cuts, and for other purposes; H.R.3, Elijah E. Cummings Lower Drug Costs Now Act; FY2022 Budget Resolution (S.Con.Res.14)/Budget Reconciliation (H.R.5376); S.2428, False Claims Amendments Act of 2021. Issues related to appropriations and federal health programs; reimbursement and vial size issues;
FY2022 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (H.R.4356/S.2599); FY2022 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.4502/S.3062); FY2022 Consolidated Appropriations Act (H.R.4502);
H.R.748, CARES Act (P.L.116-136) implementation; H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation; H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation.
HCR - Health Issues CPT - Copyright/Patent/Trademark TRD - Trade (domestic/foreign) TAX - Taxation/Internal Revenue Code MMM - Medicare/Medicaid BUD - Budget/Appropriations
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
CROSSROADS STRATEGIES, LLC
800 North Capitol Street, NW, Suite 800, Washington, DC, 20002, US
JOHN GREEN STEWART HALL TODD MATTHEW WEISS MATHEW LAPINSKI HUNTER MOORHEAD JASON BENJAMIN VAN PELT SHAY MICHAEL HANCOCK SALIM ALAMEDDIN JASON GLEASON BRITTANY JOHNSON HERNANDEZ THOMAS JOSEPH LUCAS JOHN GREEN STEWART HALL TODD MATTHEW WEISS MATHEW LAPINSKI HUNTER MOORHEAD JASON BENJAMIN VAN PELT SHAY MICHAEL HANCOCK SALIM ALAMEDDIN JASON GLEASON BRITTANY JOHNSON HERNANDEZ THOMAS JOSEPH LUCAS JOHN GREEN STEWART HALL TODD MATTHEW WEISS MATHEW LAPINSKI HUNTER MOORHEAD JASON BENJAMIN VAN PELT SHAY MICHAEL HANCOCK SALIM ALAMEDDIN JASON GLEASON BRITTANY JOHNSON HERNANDEZ THOMAS JOSEPH LUCAS JOHN GREEN STEWART HALL TODD MATTHEW WEISS MATHEW LAPINSKI HUNTER MOORHEAD JASON BENJAMIN VAN PELT SHAY MICHAEL HANCOCK SALIM ALAMEDDIN JASON GLEASON BRITTANY JOHNSON HERNANDEZ THOMAS JOSEPH LUCAS JOHN GREEN STEWART HALL TODD MATTHEW WEISS MATHEW LAPINSKI HUNTER MOORHEAD JASON BENJAMIN VAN PELT SHAY MICHAEL HANCOCK SALIM ALAMEDDIN JASON GLEASON BRITTANY JOHNSON HERNANDEZ THOMAS JOSEPH LUCAS JOHN GREEN STEWART HALL TODD MATTHEW WEISS MATHEW LAPINSKI HUNTER MOORHEAD JASON BENJAMIN VAN PELT SHAY MICHAEL HANCOCK SALIM ALAMEDDIN JASON GLEASON BRITTANY JOHNSON HERNANDEZ THOMAS JOSEPH LUCAS